Research and Markets
Drug Design of Zinc-Enzyme Inhibitors - Functional, Structural, and Disease Applications
Published in Pharma Law Weekly, October 6th, 2009
Brings together functional and structural information relevant to the design of drugs targeting zinc enzymes
The second most abundant transition element in living organisms, zinc spans all areas of metabolism, with zinc-containing proteins offering both established and potential drug targets. Drug Design of Zinc-Enzyme Inhibitors brings together functional and structural information...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2009-10-06)
More Articles from Pharma Law Weekly
- 3DIcon Corporation
3DIcon Retains Trontz Public Relations as Agency of Record - Acacia Research Corporation
Acacia Subsidiary Enters into License Agreement with Digilink Technology, Inc. - Acacia Research Corporation
Acacia Subsidiary Enters into Settlement and License Agreement with Mercedes-Benz USA - Alcohol Monitoring Systems, Inc.
Punish the Cars or Deal With the People? - American College of Physicians
Internists' new paper identifies and analyzes key drivers of health care costs - American Veterinary Medical Association
U.S. Senators Introduce Veterinary Services Legislation - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
